Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-06-16 16:35:30 ET · period of report 2026-06-15 · accession 0001636178-26-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-16 16:35 | 2026-06-15 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-06-16 16:35 | 2026-06-15 | UTHR | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $549.17 | -10.0K | 18.9K | -35% | -$5.49M |
| DT | 2026-06-16 16:35 | 2026-06-15 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | M | A | 10,000 | $117.76 | 28,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |
| 2 | Common | Common Stock | 2026-06-15 | S | D | 121 | $538.52 | 28,755 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $537.91 to $538.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-06-15 | S | D | 74 | $539.46 | 28,681 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $538.91 to $539.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-06-15 | S | D | 45 | $540.64 | 28,636 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $539.96 to $540.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-06-15 | S | D | 240 | $541.61 | 28,396 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $541.57 to $541.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-06-15 | S | D | 560 | $543.50 | 27,836 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $542.99 to $543.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-06-15 | S | D | 855 | $545.63 | 26,981 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $545.06 to $546.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-06-15 | S | D | 504 | $546.54 | 26,477 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $546.16 to $547.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-06-15 | S | D | 465 | $547.77 | 26,012 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F9) This transaction was executed in multiple trades at prices ranging from $547.25 to $548.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-06-15 | S | D | 1,616 | $548.64 | 24,396 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F10) This transaction was executed in multiple trades at prices ranging from $548.27 to $549.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-06-15 | S | D | 800 | $549.87 | 23,596 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F11) This transaction was executed in multiple trades at prices ranging from $549.34 to $550.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 12 | Common | Common Stock | 2026-06-15 | S | D | 2,200 | $550.89 | 21,396 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F12) This transaction was executed in multiple trades at prices ranging from $550.36 to $551.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 13 | Common | Common Stock | 2026-06-15 | S | D | 1,144 | $551.91 | 20,252 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F13) This transaction was executed in multiple trades at prices ranging from $551.40 to $552.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 14 | Common | Common Stock | 2026-06-15 | S | D | 778 | $553.10 | 19,474 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F14) This transaction was executed in multiple trades at prices ranging from $552.42 to $553.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 15 | Common | Common Stock | 2026-06-15 | S | D | 598 | $553.76 | 18,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F15) This transaction was executed in multiple trades at prices ranging from $553.45 to $554.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 16 | Derivative | Stock Option | 2026-06-15 | M | D | 10,000 | $0.00 | 0 | D | $117.76 · 2023-03-15 to 2027-03-15 | 10,000 Common Stock | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |